BlueCrow Capital

Founded in 2016, BlueCrow Capital is a venture capital firm based in Lisboa, Portugal. It focuses on investments in robotics & ICT, medtech, biotech, sustainable food, leisure, industrial, and agriculture sectors.

Duarte Menezes

Partner and Fund Manager

Bernardo Meira

Co-Founder and Partner

António Mello Campello

Partner

Past deals in Portugal

Maven Pet

Pre Seed Round in 2024
Maven is a SaaS pet tech startup that provides a personal vet to track the pet’s safety and health 24/7. It focuses on using technology to improve the quality of life for pets, as well as offering pet owners peace of mind and a way to keep track of their pet's safety, health, and well-being on a continual basis through their own personal veterinarian. It was started by the founders of Findster Technologies in 2021 and is based in the US and Portugal.

Oceano Fresco

Venture Round in 2024
Oceano Fresco S.A., founded in 2015 and based in Mira, Portugal, specializes in the development and production of bivalve varieties for shellfish farmers. The company focuses on enhancing the performance of these species while maintaining competitive costs and adhering to environmental sustainability principles. By employing a multi-disciplinary approach that incorporates molecular biology, genetics, animal physiology, and computational biology, Oceano Fresco selects traits that add value for shellfish farmers and bolster the sustainability and profitability of the aquaculture sector. The company collaborates with hatcheries, nurseries, and research centers to test and validate its solutions, ensuring they meet the specific needs of customers in various technical and environmental contexts. Through its vertically integrated operations and selective breeding programs, Oceano Fresco aims to provide naturally healthy and flavorful seafood while promoting responsible aquaculture practices.

Tonic App

Series A in 2024
Tonic App S.A. is a mobile application developer based in Porto, Portugal, founded in 2016. The company’s flagship application serves as a comprehensive platform for medical professionals, facilitating communication, collaboration, and information sharing among doctors. It enables users to message, share, and archive patient cases, seek expert advice, and network with peers. Tonic App is also utilized by hospitals, pharmaceutical and medical technology firms, as well as medical associations, to connect with healthcare professionals and disseminate relevant medical content. The application supports various functionalities including video consultations, clinical decision tools, and the sharing of medical images, thereby enhancing clinical work efficiency and improving patient outcomes. It is accredited as an e-library by the European Accreditation Council in CME, underscoring its commitment to quality and safety in clinical practices.

Ophiomics

Series A in 2023
Ophiomics S.A. is a clinical-stage biotech company based in Lisbon, Portugal, focused on developing innovative diagnostic products and services for liver cancer. Established in 2015, Ophiomics integrates bioinformatics, genomics, and artificial intelligence to enhance the diagnostic and prognostic capabilities in oncology. The company specializes in creating biomarker-based diagnostic devices that utilize molecular signatures combined with clinical parameters in predictive algorithms, facilitating early detection of hepatocellular carcinoma. With a commitment to quality, Ophiomics holds ISO 13485 and ISO 9001 certifications and boasts a diverse pipeline of products at various stages of development, from pre-clinical programs to those undergoing clinical validation.

Oceano Fresco

Venture Round in 2019
Oceano Fresco S.A., founded in 2015 and based in Mira, Portugal, specializes in the development and production of bivalve varieties for shellfish farmers. The company focuses on enhancing the performance of these species while maintaining competitive costs and adhering to environmental sustainability principles. By employing a multi-disciplinary approach that incorporates molecular biology, genetics, animal physiology, and computational biology, Oceano Fresco selects traits that add value for shellfish farmers and bolster the sustainability and profitability of the aquaculture sector. The company collaborates with hatcheries, nurseries, and research centers to test and validate its solutions, ensuring they meet the specific needs of customers in various technical and environmental contexts. Through its vertically integrated operations and selective breeding programs, Oceano Fresco aims to provide naturally healthy and flavorful seafood while promoting responsible aquaculture practices.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.